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Aging in Caenorhabditis elegans seems to be intimately 
tied  to  the  modulation  of  metabolism.  The  first  genes 
identified for their ability to affect life span were age-1, 
which  encodes  a  phosphatidylinositol  kinase  [1],  and 
daf-2  (constitutive  dauer  formation),  which  encodes  a 
receptor  tyrosine  kinase  similar  to  the  mammalian 
insulin and insulin-like growth factor 1 (IGF1) receptors 
[2]. Although complete loss of daf-2 function is lethal [3], 
partial  loss  of  function  extends  adult  life  by  two-  to 
threefold. daf-2 and age-1 specify steps in the insulin/
insulin-like signaling (IIS) pathway, thereby influencing 
metabolism. IIS signaling inactivates the FOXO (forkhead 
box  O)  transcription  factor  DAF-16,  which  controls 
genes that mediate a wide variety of functions, including 
metabolism,  innate  immunity,  stress  response,  and 
translation (reviewed in [4]). The modulation of life span 
by  the  IIS  pathway  seems  to  result  from  an  intricate 
network of physiological changes primarily mediated by 
unregulated  DAF-16  activity,  including  major  shifts  in 
both energy and fat metabolism.
In addition to the IIS pathway, two other main groups 
of genes have profound effects on life span and are linked 
to metabolic control: genes involved in dietary restriction 
and mitochondrial function. Dietary restriction has been 
associated with increased life span in a wide variety of 
species (including mammals) and appears to be univer-
sally associated with longevity (reviewed in [5]). Increased 
longevity resulting from mutations in genes that regulate 
mitochondrial function is more proble  matic, although, at 
least superficially, it is related to metabolic slow-down. 
Work  in  nematodes  and  other  invertebrates  seems  to 
support  the  notion  that  reducing  the  rate  of  oxidative 
phosphorylation (OXPHOS) leads to increased life span 
in two major ways: by decreasing the metabolic rate, and 
by reducing the level of reactive oxygen species, which 
are an obligate byproduct of OXPHOS. However, muta-
tions that reduce mitochondrial function are beneficial 
for C. elegans longevity, but have deleterious and often 
lethal effects in mammals [6]. The reason for this discre-
pancy is not understood.
Given the large number of genes that have been shown 
to  regulate  life  span  through  different  pathways,  it  is 
reasonable  to  ask  whether  there  are  any  physiological 
changes conducive to longevity that are common in all 
long-lived mutants. A recent metabolomic study on five 
different long-lived mutants published in BMC Biology by 
Fuchs et al. [7] suggests that the answer to this question 
may  be  yes.  Fuchs  et  al.  report  that  mutants  carrying 
three different alleles of daf-2, one allele of the insulin-
like gene daf-28 or one allele of ife-2 (translational initia-
tion factor 4E) have similar metabolic signatures, which 
cluster away from those of wild-type worms. These meta-
bolic signatures are consistent with previous findings that 
assessed gene expression in daf-2 mutants [8]. In par  ticu-
lar, they showed that long-lived daf-2 worms upregulate 
the  glyoxylate  cycle,  gluconeogenesis  and  starch 
metabo  lism.
Fuchs et al. [7] detected a common metabolic signature 
for  IIS  mutants  and  ief-2.  All  five  of  the  long-lived 
mutants had increased pools of amino acids, especially of 
the branched-chain amino acids isoleucine, leucine and 
valine,  together  with  phenylalanine  and  tyrosine.  A 
similar increase in branched-chain amino acids has been 
found in animals carrying mutations in components of 
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complexes I, II and III [9]. At least some of these ETC 
mutants are long-lived. The increase in branched-chain 
amino  acids  in  long-lived  worms  is  intriguing  for  two 
reasons. First, it opens the possibility that protein meta-
bo  lism plays an important role in life-span determination. 
Second,  branched-chain  amino  acids  are  known  to 
stimulate protein synthesis and inhibit protein degrada-
tion in higher eukaryotes [10], a phenomenon mediated 
by the TOR (target of rapamycin) pathway.
Dietary restriction and metabolism
Although  it  might  seem  reasonable  to  assume  that 
dietary  restriction  exerts  its  life-prolonging  effects  by 
reducing metabolic function, recent reports argue to the 
contrary (reviewed in [11]). Worms on a dietary restric-
tion regimen induced genetically (by eat mutations), or 
by dilution of nutrients, or by exposure to axenic medium 
(medium that supports growth without bacteria), actually 
had  increased  metabolic  rates,  as  measured  by  oxygen 
consumption  and  heat  production.  The  mechanism  by 
which dietary restriction regulates life span in worms is 
therefore not clear. While it seems to act by regulating 
the insulin pathway in Drosophila and rats, the IIS path-
way  is  not  responsible  for  dietary-restriction-induced 
longevity in C. elegans.
The most likely pathway exploited by dietary restriction 
in C. elegans is the TOR pathway. The physiological role 
of TOR kinase is to sense nutrient levels - such as cellular 
amino-acid  pools  -  and  to  regulate  transcription  and 
protein  biogenesis  and  degradation  accordingly.  TOR 
exists in two highly conserved protein complexes: TORC1, 
which  regulates  cell  growth,  protein  synthesis  and 
autophagy;  and  TORC2,  which  regulates  cytoskeletal 
reorganization [12]. Both complexes regulate the meta-
bolic state of C. elegans. TOR activates the ribosomal p70 
S6  kinase  (S6K)  and  the  translation  initiation  factor 
eIF4E. The latter is encoded by ife-2 in C. elegans, and a 
Figure 1. Possible link between accumulation of amino-acid pools, mitochondrial function, and the insulin and TOR pathways in 
C. elegans longevity. Black lines indicate the activating or repressive function of members of different signal transduction pathways. Amino-acid 
pools and other nutrients activate TOR signaling, which then results in increased translation following activation of the protein kinase S6K and the 
translation initiation factor eIFE4 and inhibition of mitochondrial biogenesis. However, mutations in DAF-2/IGF1R result in the activation of DAF-16, 
which represses daf-15 transcription to reduce TOR signaling. Red arrows indicate the effects of mutations on cellular amino-acid pools. Specifically, 
Fuchs et al. [7] show that mutations in daf-2/IGF1R, daf-28/insulin and ife-2/eIFE4 cause an increase in amino acid levels, especially branched-chain 
amino acids. Falk et al. [9] showed that mutations affecting complexes I, II and III of the electron transport chain (ETC), including some that increase 
life span, also result in accumulation of branched-chain amino acids. Mutations that confer longevity through different pathways share the 
metabolic signature of increased branched-chain amino-acid pools.
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analysis performed by Fuchs et al. [7]. It was previously 
observed  that  knockdown  of  TOR/let-363  pathway  in 
C. elegans results in an almost twofold increase in life span 
[13].  Although  not  mentioned  by  Fuchs  et  al.  [7],  their 
metabolic profiles fit very well with a model whereby TOR 
modulates  life  span  via  ife-2:  downregulation  of  TOR 
increases longevity; ife-2 is an effector of the TOR pathway 
and  animals  carrying  a  mutation  in  this  gene  also  live 
longer; and ife-2 mutants accumulate pools of amino acids 
that are known to induce protein biogenesis and inhibit 
protein  degradation.  These  data  naturally  lead  to  the 
speculation that the longevity of IIS mutants is at least 
partially derived from downregulation of TOR.
Mutation  of  DAF-15/RAPTOR,  an  activator  of  TOR, 
results in increased C. elegans life span [13]. Interestingly, 
daf-15  is  directly  regulated  by  DAF-16,  the  ultimate 
effector of the IIS pathway. It was therefore proposed that 
mutations reducing IIS signaling (such as daf-2 muta  tions) 
activate DAF-16, which then represses daf-15 to decrease 
the function of TOR and enhance longevity (Figure 1). The 
increased amino-acid pools found by Fuchs et al. [7] in the 
IIS mutants daf-2 and daf-28 could be explained by the 
consequent downregulation of TOR, which in turn would 
result in decreased translation and consequent accumu-
lation of amino-acid pools. Mutations in ife-2 would also 
result in increased amino-acid pools.
Branched-chain amino acids and longevity
Fuchs et al. [7] may, in fact, hold a clue to one of the 
mysteries of the aging field: why do translation-defective 
mutants live longer? If translation mutants such as ife-2 
accumulate amino acids, they would mimic the condi-
tions  arising  in  mitochondrial  ETC  mutants  and  IIS 
pathway  mutants.  TOR  pathway  mutants  would  be 
predicted to have very similar metabolic profiles to ETC, 
daf-2  or  ife-2  mutants.  Analyzing  the  metabolomes  of 
TOR  mutants  and  translation-defective  mutants  could 
therefore shed some light on this problem.
In  conclusion,  the  belief  that  decreased  metabolism 
leads to longevity is, so far, a generalization that extends 
beyond  the  current  evidence.  We  know  that  genes 
involved in metabolic control, such as daf-2, regulate life 
span,  but  we  do  not  know  if  overall  metabolism  is 
downregulated in these mutants [11]. For instance, daf-2 
mutants exhibit decreased carbohydrate metabolism, but 
gene-expression  data  suggest  that  lipid  utilization 
pathways are actually upregulated in these mutants [8].
Life-span-prolonging effects of downregulating protein 
synthesis  might  be  specific  to  C.  elegans  and  other 
invertebrates. The soma of the adult nematode is post-
mitotic,  and  metabolic  control  might  have  different 
effects in C. elegans (where adult cell and tissue replace-
ment does not occur) from those in higher eukaryotes, 
where compromised cells can be eliminated by apoptosis 
and  replaced.  C.  elegans  cells  might  have  a  higher 
tolerance for cellular insults and decreased metabolism. 
It  is  conceivable  that  translation  of  new  proteins  and 
other cell-maintenance processes may be more important 
to  C.  elegans  than  to  higher  organisms,  as  C.  elegans 
somatic cells cannot be replaced.
Although  the  role  of  metabolism  in  aging  is  not 
straightforward, the metabolomics of longevity mutants 
may provide some answers. It is interesting to notice that 
several  classes  of  long-lived  mutants  -  mitochondrial 
ETC mutants, IIS mutants, and translation mutants - all 
have  increased  levels  of  branched-chain  amino  acids 
[7,9].  Metabolomic  profiles  of  TOR  pathway  mutants, 
dietary restriction mutants and other translation mutants 
could  reveal  an  under-appreciated  function  of  amino-
acid metabolism in longevity.
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